Douglas A. Treco - 25 Jun 2025 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role: CEO & Chairman, Director
Signature: /s/ Sanjay Subramanian, as attorney-in-fact for Douglas A. Treco
Issuer symbol: INZY
Transactions as of: 25 Jun 2025
Net transactions value: +$2,083
Form type: 4
Filing time: 27 Jun 2025, 16:05:09 UTC
Previous filing: 06 Jun 2025
Next filing: 03 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Treco Douglas A	CEO & Chairman, Director	C/O INOZYME PHARMA, INC., 321 SUMMER STREET SUITE 400, BOSTON	/s/ Sanjay Subramanian, as attorney-in-fact for Douglas A. Treco	27 Jun 2025	0001688192

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INZY	Common Stock	Award	$2,083	+2,815	+6.9%	$0.7400	43,861	25 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2025 through June 25, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on April 1, 2025, the first trading day of the purchase period.